Italy · AIFA medicine catalogue
TYSABRI
A source-listed package record. Different packs may share the same medicine name.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 037150036
- Form
- Soluzione iniettabile in siringa pre-riempita
- Composition / generic term
- NATALIZUMAB
- Company as listed by source
- BIOGEN NETHERLANDS BV
- Source status
- Autorizzata
- Supply classification
- Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile
Source-listed ingredients
- NATALIZUMAB
These values do not establish equivalence or a dose recommendation.
Packages
- 150 mg - Soluzione iniettabile - Uso sottocutaneo - Siringa preriempita (vetro) 1 ml (150 mg/ml) - 6 (3x2) siringhe preriempite (confezione multipla)
Source and coverage
Open AIFA medicine catalogue →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Italy records →